Research programme: bacterial and viral vaccines - IDM Pharma/Berna Rhein
Latest Information Update: 21 Oct 2008
At a glance
- Originator Berna Rhein; IDM Pharma
- Class Vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections; Viral infections
Most Recent Events
- 18 Aug 2005 IDM S.A. has merged with Epimmune to form IDM Pharma
- 31 Oct 2002 Rhein Biotech has been acquired by Berna Biotech
- 16 Jan 2002 Preclinical development for Bacterial infections in Netherlands (Unknown route)